NKF KDOQI Clinical Practice Guidelines

NKF KDOQI Clinical Practice Guidelines

World renowned for improving the diagnosis and treatment of kidney disease, these guidelines have changed the practices of healthcare professionals and improved thousands of lives.

Quality measures, when adopted by payers and health systems, are another powerful tool to promote evidence-based care. In 2022, KDOQI began a new Quality Measurement initiative.

KDOQI strives to make clinical practice guideline development as transparent and efficient as possible. It generally takes 18-24 months from development of a scope of work to submission of the manuscript to AJKD.
All KDOQI Guidelines and Commentaries are published in the American Journal of Kidney Diseases (AJKD), NKF's premier journal.


This group provides overall direction and ongoing guidance to the KDOQI initiative. They interact closely with project work groups and work group chairs, preside over KDOQI meetings, and serve as KDOQI spokespeople. 

NKF KDOQI app now available!

Download now to access guidelines and commentaries at your fingertips.

KDOQI 20th Anniversary

Discover the history of the first broadly accepted clinical practice guidelines in nephrology, now known as KDOQI—Kidney Disease Outcomes Quality Initiative.

Help shape KDOQI

Help us identify future controversies topics by completing the below poll. We greatly appreciate your participation and welcome feedback for future topics!

Suggestions for future topics? Click here to share your ideas!